Trial Profile

Biologic Therapy to Prevent Osteoarthritis After ACL Injury

Status: Recruiting

Phase of Trial: Phase 0

Latest Information Update: 25 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Anakinra (Primary)
Indications Osteoarthritis
Focus Therapeutic Use

Most Recent Events

18 Jun 2022 According to ClinicalTrials.gov record, protocol has been amended to decrease patient number from 48 to 32, treatment arm from 3 to 2. In primary endpoint the time for Synovial fluid collection changes from within 7 days and 10 days to within 2 weeks and 3-5 days.
18 Jun 2022 Planned number of patients changed from 48 to 32.
18 Jun 2022 Planned End Date changed from 30 May 2023 to 30 May 2024.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com